189 related articles for article (PubMed ID: 9045955)
21. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
22. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
Yang B; Guo M; Herman JG; Clark DP
Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176
[TBL] [Abstract][Full Text] [Related]
24. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
Park HJ; Yu E; Shim YH
Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
[TBL] [Abstract][Full Text] [Related]
25. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of methylation and loss of heterozygosity of RUNX3 gene in hepatocellular carcinoma and its clinical significance].
Xiao WH; Liu WW
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):227-30. PubMed ID: 15099475
[TBL] [Abstract][Full Text] [Related]
27. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.
Zhang WD; Hirohashi S; Tsuda H; Shimosato Y; Yokota J; Terada M; Sugimura T
Jpn J Cancer Res; 1990 Feb; 81(2):108-11. PubMed ID: 1970554
[TBL] [Abstract][Full Text] [Related]
28. Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas.
Tian Y; Arai E; Makiuchi S; Tsuda N; Kuramoto J; Ohara K; Takahashi Y; Ito N; Ojima H; Hiraoka N; Gotoh M; Yoshida T; Kanai Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2461-2477. PubMed ID: 32685988
[TBL] [Abstract][Full Text] [Related]
29. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
Slagle BL; Zhou YZ; Butel JS
Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
[TBL] [Abstract][Full Text] [Related]
31. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
[TBL] [Abstract][Full Text] [Related]
32. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
Ding SF; Habib NA; Dooley J; Wood C; Bowles L; Delhanty JD
Br J Cancer; 1991 Dec; 64(6):1083-7. PubMed ID: 1684907
[TBL] [Abstract][Full Text] [Related]
33. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
34. Alterations in gene expression associated with the overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, during human hepatocarcinogenesis.
Kanai Y; Saito Y; Ushijima S; Hirohashi S
J Cancer Res Clin Oncol; 2004 Nov; 130(11):636-44. PubMed ID: 15490234
[TBL] [Abstract][Full Text] [Related]
35. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients.
Chang H; Yi B; Li L; Zhang HY; Sun F; Dong SQ; Cao Y
Exp Mol Pathol; 2008 Oct; 85(2):96-100. PubMed ID: 18691570
[TBL] [Abstract][Full Text] [Related]
36. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma.
Kishimoto Y; Shiota G; Kamisaki Y; Wada K; Nakamoto K; Yamawaki M; Kotani M; Itoh T; Kawasaki H
Oncology; 1997; 54(4):304-10. PubMed ID: 9216855
[TBL] [Abstract][Full Text] [Related]
37. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.
Hlady RA; Tiedemann RL; Puszyk W; Zendejas I; Roberts LR; Choi JH; Liu C; Robertson KD
Oncotarget; 2014 Oct; 5(19):9425-43. PubMed ID: 25294808
[TBL] [Abstract][Full Text] [Related]
39. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
[TBL] [Abstract][Full Text] [Related]
40. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
De Miglio MR; Muroni MR; Simile MM; Virdis P; Asara G; Frau M; Calvisi DF; Seddaiu MA; Pascale RM; Feo F
Hepatology; 2001 May; 33(5):1110-7. PubMed ID: 11343238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
